THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DAEPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

Vassilakopoulos T., FERHANOĞLU A. B., Horowitz N. A., Apostolidis J., Mellios Z., Piperidou A., ...Daha Fazla

28th Congress of the European Hematology Association, 8 - 15 Haziran 2023, ss.2276-2277

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Sayfa Sayıları: ss.2276-2277
  • İstanbul Medipol Üniversitesi Adresli: Evet